Vimarsana
Biggest News Aggregation in the World

Page 13 - C Diff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from C Diff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In C Diff Today - Breaking & Trending Today

Bacterial species known for causing diarrheal infections may also drive colorectal cancer - Vimarsana News

Bacterial species known for causing diarrheal infections may also drive colorectal cancer

Data collected by researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy suggest that Clostridioides difficile, or C. diff, a bacterial species well known for causing serious diarrheal infections, may also drive colorectal cancer.

Inappropriate antibiotic prescriptions for children associated with excess health-care costs - Vimarsana News

Inappropriate antibiotic prescriptions for children associated with excess health-care costs

Antibiotics inappropriately prescribed to nonhospitalized children resulted in at least $74 million in excess health-care costs in the U.S. in 2017, according to a new study from Washington University School of Medicine in St. Louis and The Pew Charitable Trusts.

Antibiotics disrupt the immune system in the gut leading to fungal infection - Vimarsana News

Antibiotics disrupt the immune system in the gut leading to fungal infection

Patients prescribed antibiotics in hospital are more likely to get fungal infections because of disruption to the immune system in the gut, according to a new study from the University of Birmingham and National Institutes of Health.

Ferring to Present Analyses for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C. Difficile Infection at DDW 2022 - Vimarsana News

Ferring to Present Analyses for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C. Difficile Infection at DDW 2022

Ferring to Present Analyses for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C. Difficile Infection at DDW 2022.

How UCSF's data science team took on COVID - Vimarsana News

How UCSF's data science team took on COVID

COVID-19 was the biggest data story of the past several decades, and the UCSF data...